Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Diamond482on Mar 31, 2016 10:54pm

104 Views

Post# 24718243

RE:RE:With a 15% allowance for "attrition"-look for phase III HALT

Beyond that ........what I do "expect" is an announcement in between those dates that the FDA will grant "early access/compassionate use " Then things should roll.

Bullboard Posts

Rich TV Live's Stocks to Watch this week (May 31, 2024)